The beneficial effects of sodium glucose co-transporter-2 inhibitor in type 2 diabetes patients with multiple risk factors needs to be explored further: a meta-analysis
Event: ESC Preventive Cardiology 2023
Topic: Cardiovascular Disease in Special Populations, Other
Session: Moderated ePoster 31
